Screener
Bolt Biotherapeutics, Inc. BOLT Q3 2025 earnings
Reported November 12, 2025 · Before market open
Revenue$2.2MBeat by $1.3M
EPS-$3.72Beat by $1.35
Revenue estimate$820.8K
EPS estimate-$5.07
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$68.3K
EPS estimate-$3.89
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bolt Biotherapeutics, Inc. report Q3 2025 earnings?
- Bolt Biotherapeutics, Inc. (BOLT) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Bolt Biotherapeutics, Inc.'s Q3 2025 revenue and EPS?
- Bolt Biotherapeutics, Inc. reported revenue of $2.2M and eps of $-3.72 for Q3 2025.
- Did Bolt Biotherapeutics, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $820.8K by $1.3M. EPS beat the consensus estimate of $-5.07 by $1.35.
- How did Bolt Biotherapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 90.1% from $1.1M a year earlier and eps declined 830.0% from $-0.40.
- Where can I find Bolt Biotherapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-277521) and the 10-Q periodic report (0001193125-25-277549) directly on SEC EDGAR. The filing index links above go to sec.gov.
